Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children
Clinical trial NCT04659733 · UNKNOWN
Trial details
- NCT number
- NCT04659733
- Sponsor
- Yizhuo Zhang
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-30
- Primary completion
- 2022-12-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.